Actinic Keratosis Step Therapy Criteria
Customize your policy alerts
Sign up for all clover_health policy alerts
Know when clover_health releases new policies or updates existing guidance.
Monitor payer policy activity
Establishes step-therapy requirements for selected prescription products, including diclofenac sodium gel 3% and medications in antidepressant, atypical antipsychotic, SGLT2 inhibitor, and other therapy categories.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.